@Article{crph914,
AUTHOR = {Ojiaku, Onyekachi Darlington Bennette and Duru, Pius Chukwudi and Ikwuka, Aloysius Obinna and Udeh, Francis Chigozie},
TITLE = {Optimization of Delirium Care in Adult Patients with Cancer: A Comprehensive and Integrative Review of Efficacy and Patient Outcomes},
JOURNAL = {Current Research in Public Health},
VOLUME = {4},
YEAR = {2024},
NUMBER = {1},
PAGES = {7-22},
URL = {https://www.scipublications.com/journal/index.php/WJCMR/article/view/914},
ISSN = {2831-5162},
DOI = {10.31586/wjcmr.2024.914},
ABSTRACT = {Delirium is a major complication most commonly observed in patients with advanced cancer. However, despite its prevalence, the early diagnosis, management, and prevention of this condition have not seen significant progress. Aim of this research is to provide insights into the prevalence of delirium, the optimization of interventions for managing delirium symptoms, their effectiveness and the impact of underlying factors on the reversibility of delirium in advanced cancer patients receiving palliative care. The review involved systematic searches of relevant databases including MEDLINE, CINAHL, ProQuest Nursing and Allied Health, and PsychInfo using refined search terms. Eight publications out of 614 studies originally searched were selected and critically reviewed. Their quality was assessed using Joanna Briggs Institute's Critical Appraisal Tool for Case Series. Data abstraction and content analysis were performed to synthesize the findings. Delirium is prevalent among advanced cancer patients in palliative care, with rates ranging from 10.3% to 24.1%. Pharmacotherapy and non-pharmacological interventions showed effectiveness in reducing delirium symptoms. Delirium was found to be reversible through palliative care interventions, antipsychotic medications, and exercise therapy. Effective delirium management is crucial in improving the quality of life of cancer patients. This review emphasizes the importance of subtype-specific treatments, standardized guidelines, and long-term follow-up studies. Implementing evidence-based individualized approaches to delirium management can optimize treatment efficacy and clinical outcomes in patients as well as improve the quality of care. Tailored interventions, standardized protocols, and further research are hereby recommended.},
}

%0 Journal Article
%A Ojiaku, Onyekachi Darlington Bennette
%A Duru, Pius Chukwudi
%A Ikwuka, Aloysius Obinna
%A Udeh, Francis Chigozie
%D 2024
%J Current Research in Public Health

%@ 2831-5162
%V 4
%N 1
%P 7-22

%T Optimization of Delirium Care in Adult Patients with Cancer: A Comprehensive and Integrative Review of Efficacy and Patient Outcomes
%M doi:10.31586/wjcmr.2024.914
%U https://www.scipublications.com/journal/index.php/WJCMR/article/view/914

TY  - JOUR
AU  - Ojiaku, Onyekachi Darlington Bennette
AU  - Duru, Pius Chukwudi
AU  - Ikwuka, Aloysius Obinna
AU  - Udeh, Francis Chigozie
TI  - Optimization of Delirium Care in Adult Patients with Cancer: A Comprehensive and Integrative Review of Efficacy and Patient Outcomes
T2  - Current Research in Public Health
PY  - 2024
VL  - 4
IS  - 1
SN  - 2831-5162
SP  - 7
EP  - 22
UR  - https://www.scipublications.com/journal/index.php/WJCMR/article/view/914
AB  - Delirium is a major complication most commonly observed in patients with advanced cancer. However, despite its prevalence, the early diagnosis, management, and prevention of this condition have not seen significant progress. Aim of this research is to provide insights into the prevalence of delirium, the optimization of interventions for managing delirium symptoms, their effectiveness and the impact of underlying factors on the reversibility of delirium in advanced cancer patients receiving palliative care. The review involved systematic searches of relevant databases including MEDLINE, CINAHL, ProQuest Nursing and Allied Health, and PsychInfo using refined search terms. Eight publications out of 614 studies originally searched were selected and critically reviewed. Their quality was assessed using Joanna Briggs Institute's Critical Appraisal Tool for Case Series. Data abstraction and content analysis were performed to synthesize the findings. Delirium is prevalent among advanced cancer patients in palliative care, with rates ranging from 10.3% to 24.1%. Pharmacotherapy and non-pharmacological interventions showed effectiveness in reducing delirium symptoms. Delirium was found to be reversible through palliative care interventions, antipsychotic medications, and exercise therapy. Effective delirium management is crucial in improving the quality of life of cancer patients. This review emphasizes the importance of subtype-specific treatments, standardized guidelines, and long-term follow-up studies. Implementing evidence-based individualized approaches to delirium management can optimize treatment efficacy and clinical outcomes in patients as well as improve the quality of care. Tailored interventions, standardized protocols, and further research are hereby recommended.
DO  - Optimization of Delirium Care in Adult Patients with Cancer: A Comprehensive and Integrative Review of Efficacy and Patient Outcomes
TI  - 10.31586/wjcmr.2024.914
ER  -